Medical liquid composition for aerial administration
US-2024358636-A1 · Oct 31, 2024 · US
US10406107B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10406107-B2 |
| Application number | US-201313909516-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 4, 2013 |
| Priority date | Jun 15, 2012 |
| Publication date | Sep 10, 2019 |
| Grant date | Sep 10, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Provided is a base material for dry direct tableting, the material being excellent in a binding property and disintegrability. More specifically, provided is a method of preparing a composite granule comprising at least a step of granulating a second sugar or sugar alcohol while adding thereto an aqueous dispersion comprising at least low-substituted hydroxypropyl cellulose having a degree of hydroxypropoxy substitution of 5 to 16% by weight, polyvinyl alcohol, a first sugar or sugar alcohol, and water.
Opening claim text (preview).
The invention claimed is: 1. A method of preparing a composite granule for tableting, comprising at least a step of granulating a second sugar or sugar alcohol while spraying thereto an aqueous dispersion comprising at least low-substituted hydroxypropyl cellulose having a degree of hydroxypropoxy substitution of 5 to 16% by weight, polyvinyl alcohol, a first sugar or sugar alcohol, and water, wherein the aqueous dispersion coats a surface of the second sugar or sugar alcohol for surface-modification of the second sugar or sugar alcohol with the low-substituted hydroxypropyl cellulose and the polyvinyl alcohol, and wherein the composite granule is characterized by the absence of a drug except for the first sugar or sugar alcohol and the second sugar or sugar alcohol. 2. The method of preparing a composite granule according to claim 1 , wherein the first sugar or sugar alcohol and the second sugar or sugar alcohol may be the same or different and are each at least one selected from the group consisting of mannitol, trehalose, xylitol, erythritol, lactose and sucrose. 3. The method of preparing a composite granule according to claim 1 , wherein the low-substituted hydroxypropyl cellulose is comprised in an amount of 1 to 15 parts by weight based on 100 parts by weight of a total amount of the first sugar or sugar alcohol and the second sugar or sugar alcohol. 4. The method of preparing a composite granule according to claim 1 , wherein the polyvinyl alcohol is comprised in an amount of 0.05 to 0.4 parts by weight based on 100 parts by weight of a total amount of the first sugar or sugar alcohol and the second sugar or sugar alcohol. 5. A rapid release tablet comprising at least the composite granule prepared by the method as claimed in claim 1 and a drug, and being obtained by mixing the composite granule with the drug.
Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates · CPC title
Cellulose; Derivatives thereof · CPC title
having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol · CPC title
Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals · CPC title
Ascorbic acid, i.e. vitamin C; Salts thereof · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.